Single CAR T infusion shows strong response in patients with high-risk smoldering multiple myeloma

A single infusion of ciltacabtagene autoleucel (Carvykti) led to a 100% minimal residual disease (MRD)-negativity rate in patients with high-risk smoldering multiple myeloma, according to results from CAR-PRISM, a phase…

Continue ReadingSingle CAR T infusion shows strong response in patients with high-risk smoldering multiple myeloma

CBD shows promise, but this review warns the hype is outpacing the science

A Neuropsychopharmacology Circumspectives article argues that cannabidiol has genuine therapeutic potential, especially in treatment-resistant pediatric epilepsy, but evidence for most other uses remains limited, heterogeneous, and not yet mature enough…

Continue ReadingCBD shows promise, but this review warns the hype is outpacing the science